This secondary analysis of a randomized clinical trial examines the association between driver alterations and the risk of mutations and prognosis in women with postmenopausal hormone receptor–positive, HER2-negative breast cancer.
https://ift.tt/2l7GFOg
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου